BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Merck’s Keytruda Approved for First-Line Treatment of Colorectal Cancer

  The anti-PD-1 therapy was approved by the U.S. Food and Drug Administration alone for first-line treatment of unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  BioCapital

  Mutated COVID-19 Viral Strain in U.S. and Europe 10 Times More Contagious than Original Strain

  Researchers have found that the strains spreading so quickly in Europe and the U.S. have a mutated S “spike” protein that makes it about 10 times more infectious than the strain that originally was identified in Asia.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy Collaboration

  Cambridge, Massachusetts-based Carmine Therapeutics inked a research collaboration deal with Japan’s Takeda Pharmaceutical to develop and commercialize non-viral gene therapies for two rare diseases.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Inovio’s COVID-19 Vaccine Suggests Overall Immune Responses in Phase I Trial

  INO-4800 is one of the experimental vaccines included in the U.S. government’s Operation Warp Speed that has a goal of having a vaccine available by January 2021.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Biopharma Update on the Novel Coronavirus: July 1

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 1, 2020.

  June 30, 2020

   · 

  3 min read

   · 

  BioSpace Editorial Staff
• 

  Job Trends

  Biopharma Companies Continue to Expand, Add Jobs Despite Ongoing Pandemic

  Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.

  June 30, 2020

   · 

  5 min read

   · 

  Ellen Bombela
• 

  Policy

  FDA Sets Bar for COVID-19 Vaccine Approval at 50% Effectiveness

  The FDA guidelines also indicated a vaccine would not be approved unless it had “clearly demonstrated” proof of the vaccine’s safety and effectiveness in a clinical trial.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Career Advice

  4 Ways to Stay Productive if You’ve Been Furloughed

  If you’ve been furloughed, it’s normal to feel some apprehension, fear and/or doubt about your employment. These are four ways to stay productive if you’ve been furloughed.

  June 30, 2020

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  Business

  Freeline Raises $120 Million to Advance Gene Therapy Programs

  This was on top of Syncona’s previously announced Series C investment in Freeline of $40 million, with another $80 million in new capital.

  June 30, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Could Interferons Be A Potent Weapon Against COVID-19?

  Interferons are proteins produced by the body to fight viral infections by inhibiting its replication in the body.

  June 30, 2020

   · 

  3 min read

   · 

  Alex Keown